You are here

Global List Event

Updates on Indications, Interactions and Complications in the Uses of Pharmaceuticals Mediterranean Cruise

Continuing Education, Inc

Drug Abuse and Misuse (3 hrs)
  • Identify the dangers associated with the nonmedical use of prescription and OTC medications.
  • Recognize the patient characteristics and techniques that may suggest the possibility of diversion/mis-use.
  • Identify ways to prevent medication abuse in your patients and drug diversion within your practice.
  • Compare and contrast challenges with Prescription Drug Monitoring Programs and behind the counter status.
  • Discuss the use of marijuana (and its active ingredients) for various medicinal purposes.

Understanding Patient’s Approaches in Self-Care (2hrs)

  • Define self-care and describe patient’s attitude about self-care.
  • Outline strategies for assessing and counseling patients on the use of OTC products in self-care.
  • Describe patient’s attitudes about monitoring devices and diagnostics for self-care.
  • Identify new personal health care technologies and the impact they may have on patient outcomes.

Optimizing Medication Adherence and Outcomes (2hrs)

  • Define medication compliance, adherence, and persistency.
  • Identify strategies to promote medications adherence among all healthcare providers.
  • Describe the impact of poor adherence on clinical and economic outcomes for patient and stakeholders.
  • List common sources for miscommunication in health care that can lead to potentially serious medical errors.
  • Describe the necessary points within the medication use system in which technology can be employed to reduce medical errors and enhance patient outcomes.

From Pharmacogenomics to Personalized Medicine (2hrs)

  • Describe the benefits and limitations of genetic testing and use in managing medications in specific patients.
  • Discuss the use of new technologies such a laboratory-developed tests (LDTs) by the general public.
  • Identify new personal health care technologies and the impact they may have on patient outcomes.
  • Recognize various gene-drug (biomarker-drug) pairs with pharmacogenomic applications.

Pharmaceutical Regulatory Update and Key Product Approvals (3hrs)

  • Identify key brand to generic approvals as well as prescription to over-the-counter approvals.
  • Compare and contrast key recent drug approvals with those already used for specific conditions.
  • Discuss important patient counseling and therapeutic monitoring considerations for new drugs approvals.
  • Describe the challenges associated with biosimilars and biologics and their interchangeability.
  • Outline the FDA's role in post-marketing safety surveillance for medical and pharmaceutical products.

Creating Highly Effective Health Care Teams (2hrs)

  • Describe the benefits and limitations of collaborative practice models in various patient care settings.
  • Recognize the importance of aligning incentives in a “pay for performance” model that includes all providers.
  • Describe the elements necessary (patient data) necessary to support improvements in health outcomes.
  • Discuss the rationale for collaborative models of care that deliver enhanced patient and economic outcomes.
Apr 2016
10
Apr 2016
17

Address details

Barcelona
Barcelona
Spain

Location information

Aboard Holland America's ms Eurodam